S&P 500   3,247.97 (-2.69%)
DOW   28,151.49 (-2.90%)
QQQ   222.72 (-3.28%)
AAPL   299.71 (-4.26%)
FB   203.38 (-3.24%)
MSFT   171.85 (-3.77%)
GOOGL   1,427.99 (-3.74%)
AMZN   2,028.43 (-3.22%)
CGC   20.59 (-5.90%)
NVDA   274.57 (-6.63%)
BABA   205.40 (-3.38%)
MU   54.30 (-4.72%)
GE   11.89 (-2.94%)
TSLA   854.46 (-5.17%)
AMD   48.78 (-8.45%)
ACB   1.57 (-5.99%)
NFLX   368.24 (-3.11%)
PRI   127.89 (-3.36%)
BAC   33.07 (-3.75%)
DIS   133.32 (-4.07%)
GILD   72.44 (+3.93%)
S&P 500   3,247.97 (-2.69%)
DOW   28,151.49 (-2.90%)
QQQ   222.72 (-3.28%)
AAPL   299.71 (-4.26%)
FB   203.38 (-3.24%)
MSFT   171.85 (-3.77%)
GOOGL   1,427.99 (-3.74%)
AMZN   2,028.43 (-3.22%)
CGC   20.59 (-5.90%)
NVDA   274.57 (-6.63%)
BABA   205.40 (-3.38%)
MU   54.30 (-4.72%)
GE   11.89 (-2.94%)
TSLA   854.46 (-5.17%)
AMD   48.78 (-8.45%)
ACB   1.57 (-5.99%)
NFLX   368.24 (-3.11%)
PRI   127.89 (-3.36%)
BAC   33.07 (-3.75%)
DIS   133.32 (-4.07%)
GILD   72.44 (+3.93%)
S&P 500   3,247.97 (-2.69%)
DOW   28,151.49 (-2.90%)
QQQ   222.72 (-3.28%)
AAPL   299.71 (-4.26%)
FB   203.38 (-3.24%)
MSFT   171.85 (-3.77%)
GOOGL   1,427.99 (-3.74%)
AMZN   2,028.43 (-3.22%)
CGC   20.59 (-5.90%)
NVDA   274.57 (-6.63%)
BABA   205.40 (-3.38%)
MU   54.30 (-4.72%)
GE   11.89 (-2.94%)
TSLA   854.46 (-5.17%)
AMD   48.78 (-8.45%)
ACB   1.57 (-5.99%)
NFLX   368.24 (-3.11%)
PRI   127.89 (-3.36%)
BAC   33.07 (-3.75%)
DIS   133.32 (-4.07%)
GILD   72.44 (+3.93%)
S&P 500   3,247.97 (-2.69%)
DOW   28,151.49 (-2.90%)
QQQ   222.72 (-3.28%)
AAPL   299.71 (-4.26%)
FB   203.38 (-3.24%)
MSFT   171.85 (-3.77%)
GOOGL   1,427.99 (-3.74%)
AMZN   2,028.43 (-3.22%)
CGC   20.59 (-5.90%)
NVDA   274.57 (-6.63%)
BABA   205.40 (-3.38%)
MU   54.30 (-4.72%)
GE   11.89 (-2.94%)
TSLA   854.46 (-5.17%)
AMD   48.78 (-8.45%)
ACB   1.57 (-5.99%)
NFLX   368.24 (-3.11%)
PRI   127.89 (-3.36%)
BAC   33.07 (-3.75%)
DIS   133.32 (-4.07%)
GILD   72.44 (+3.93%)
Log in

LON:NCYT - Novacyt Share Price, Forecast & News

GBX 138.25
+33.25 (+31.67 %)
(As of 02/24/2020 09:44 AM ET)
Today's Range
127.50
Now: GBX 138.25
190
50-Day Range
14
MA: GBX 41.09
166
52-Week Range
6.03
Now: GBX 138.25
80
Volume7.01 million shs
Average VolumeN/A
Market Capitalization£82.64 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Novacyt S.A. develops and sells diagnostic products for cancer and infectious diseases. The company's diagnostic products are used in liquid based cytology, oncology, microbiology, haematology, and serology testing. It offers NovaPrep, a liquid based cytology solution that is utilized in the diagnosis of cervical cancer; and clinical laboratory testing services to clinicians, healthcare providers, and patients. The company also develops, manufactures, and distributes diagnostic products for clinical and food laboratories; and manufactures and markets vitro diagnostic tests, as well as diagnostic reagents, test kits, and blood grouping reagents. It serves hospitals and large corporates. The company was founded in 2006 and is based in Vélizy-Villacoublay, France.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone33 1 39 46 51 04

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book ValueGBX 116.20 per share

Profitability

Miscellaneous

Employees121
Market Cap£82.64 million
Next Earnings DateN/A
OptionableNot Optionable

Receive NCYT News and Ratings via Email

Sign-up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter.


Novacyt (LON:NCYT) Frequently Asked Questions

What is Novacyt's stock symbol?

Novacyt trades on the London Stock Exchange (LON) under the ticker symbol "NCYT."

Has Novacyt been receiving favorable news coverage?

Media headlines about NCYT stock have been trending negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Novacyt earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an effect on the stock's share price in the next several days. View News Stories for Novacyt.

Who are some of Novacyt's key competitors?

What other stocks do shareholders of Novacyt own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Novacyt investors own include Onconova Therapeutics (ONTX), Merus (MRUS), GENFIT S A/ADR (GNFT) and Capstone Turbine (CPST).

Who are Novacyt's key executives?

Novacyt's management team includes the folowing people:
  • Mr. Graham Mullis, CEO & Director (Age 56)
  • Mr. Anthony Dyer, CFO, Company Sec. & Director
  • Ms. Mandy Cowling, Corp. & Investor Relations Mang.
  • Ms. Wendy Karban, Group HR Mang.
  • Mr. Phillip Sefton, Managing Director of Lab21 Products Division

How do I buy shares of Novacyt?

Shares of NCYT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Novacyt's stock price today?

One share of NCYT stock can currently be purchased for approximately GBX 138.25.

How big of a company is Novacyt?

Novacyt has a market capitalization of £82.64 million. Novacyt employs 121 workers across the globe.View Additional Information About Novacyt.

What is Novacyt's official website?

The official website for Novacyt is http://www.novacyt.com/.

How can I contact Novacyt?

The company can be reached via phone at 33 1 39 46 51 04.


MarketBeat Community Rating for Novacyt (LON NCYT)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  29 (Vote Outperform)
Underperform Votes:  44 (Vote Underperform)
Total Votes:  73
MarketBeat's community ratings are surveys of what our community members think about Novacyt and other stocks. Vote "Outperform" if you believe NCYT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NCYT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Featured Article: Municipal Bonds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel